Compugen | CGEN - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Arca Biopharma USD 15.37M 5.59M 2025-12
aTyr Pharma USD 113.19M 97.51M 2025-12
Bio Path USD 8.68M 819K 2025-09
Brainstorm Cell Therapeutics USD 9.02M 495K 2025-09
Cara Therapeutics USD 10.68M 9.48M 2025-06
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.57M 2.29M 2025-12
Immunic USD 30.08M 2.77M 2025-09
Infinity Pharmaceuticals USD 12.06M 775K 2023-06
Minerva Neurosciences USD 2.29M 381K 2025-12
RedHill Biopharma USD 22.29M 64K 2025-06
TherapeuticsMD USD 5.82M 655K 2024-06